seizure Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials

Male only (23)
Female only (76)
Any (1011)

Phase 0 (1)
Phase 1 (24)
Phase 2 (74)
Phase 3 (56)
Phase 4 (48)
Phase 1/2 (24)
Phase 2/3 (18)
Unknown (865)

Interventional (773)
Observational (309)

VA Office of Research and Development (20)
Johns Hopkins University (13)
Hospices Civils de Lyon (12)
University of California, San Francisco (11)
Assistance Publique - Hôpitaux de Paris (10)
Mayo Clinic (9)
National Taiwan University Hospital (9)
Assistance Publique Hopitaux De Marseille (8)
Lawson Health Research Institute (8)
Massachusetts General Hospital (8)
National Institute of Neurological Disorders and Stroke (NINDS) (8)
Northwestern University (8)
University of Colorado, Denver (8)
Chinese University of Hong Kong (7)
Second Affiliated Hospital, School of Medicine, Zhejiang University (7)
The University of Hong Kong (7)
University of Alabama at Birmingham (7)
University of British Columbia (7)
Duke University (6)
National Cancer Institute (NCI) (6)
Northwell Health (6)
UCB Biopharma SRL (6)
Universitaire Ziekenhuizen Leuven (6)
University Hospital, Grenoble (6)
University Hospital, Toulouse (6)
University of Illinois at Chicago (6)
Washington University School of Medicine (6)
Children's Hospital Los Angeles (5)
Children's Hospital of Fudan University (5)
Columbia University (5)
Indiana University (5)
University Hospital, Basel, Switzerland (5)
University Hospital, Ghent (5)
University of Florida (5)
Western University, Canada (5)
Baylor College of Medicine (4)
Centre hospitalier de l'Université de Montréal (CHUM) (4)
Children's Hospital Medical Center, Cincinnati (4)
Dartmouth-Hitchcock Medical Center (4)
Fondation Ophtalmologique Adolphe de Rothschild (4)
McMaster University (4)
Medical University of Vienna (4)
New York State Psychiatric Institute (4)
Radboud University (4)
The Cleveland Clinic (4)
University Health Network, Toronto (4)
University Hospital Inselspital, Berne (4)
University of Alberta (4)
University of California, San Diego (4)
University of Iowa (4)
University of Minnesota (4)
University of Oxford (4)
University of Pittsburgh (4)
University of Texas Southwestern Medical Center (4)
University of Utah (4)
University of Washington (4)
University of Wisconsin, Madison (4)
Vanderbilt University Medical Center (4)
Weill Medical College of Cornell University (4)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (3)
CHU de Reims (3)
Cairo University (3)
Eisai Inc. (3)
Emory University (3)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)
King's College London (3)
Leiden University Medical Center (3)
McGill University Health Centre/Research Institute of the McGill University Health Centre (3)
MedtronicNeuro (3)
NYU Langone Health (3)
National Institute of Mental Health (NIMH) (3)
Rigshospitalet, Denmark (3)
St. Justine's Hospital (3)
Sun Yat-sen University (3)
The Hospital for Sick Children (3)
University Hospital, Montpellier (3)
University of Arizona (3)
University of Calgary (3)
University of California, Los Angeles (3)
University of Chicago (3)
University of Michigan (3)
University of Nebraska (3)
University of New Mexico (3)
University of Pennsylvania (3)
University of Sao Paulo (3)
Uppsala University (3)
Wuerzburg University Hospital (3)
Yale University (3)
Yu-Hsiang Wu (3)
AHS Cancer Control Alberta (2)
Advanced Bionics AG (2)
Aga Khan University (2)
Assiut University (2)
Beijing Children's Hospital (2)
Beijing Tiantan Hospital (2)
Boston Children's Hospital (2)
Boston Scientific Corporation (2)
Brigham and Women's Hospital (2)
Case Comprehensive Cancer Center (2)
Central Hospital, Nancy, France (2)

No (847)
Yes (263)

Updated trials (98)
New trials (18)

I am/have/had

I am/have/hadepilepsy

I am/have/hadcancer

I am/have/hadpartial seizure

I am/have/hadmeasurable disease

I am/have/hadeeg monitoring

I am/have/hadbody mass index

I am/have/hadvagus nerve stimulation

I am/have/hadneutrophil count

I am/have/hadketogenic diet

I am/have/hadelectroencephalogram

I am/have/hadepilepsy surgery

I am/have/haddepression

I am/have/hadscalp eeg

I am/have/hadendoscopy

I am/have/hadheadache

I am/have/hadfecal immunochemical test

I am/have/hadepilepsy monitoring

I am/have/haddiscomfort

I am/have/hadanesthesia

I am/have/hadscreening for colorectal cancer

added new label for I am/have/had

I am looking for

I am looking forantiepileptics

I am looking forlevetiracetam

I am looking fortonic

I am looking foroxcarbazepine

I am looking forperampanel

I am looking foranti-epileptic drug

I am looking forcarboplatin

I am looking forceftobiprole

I am looking forchemotherapy drug

I am looking formonoclonal antibodies

I am looking forvenetoclax

I am looking foranesthesia

I am looking forendocrine therapy

I am looking forrituximab

I am looking foroxaliplatin

I am looking forfluorouracil

I am looking forcapecitabine

I am looking forantibiotics

I am looking forerbb2

I am looking formonoclonal protein

added new label for I am looking for

Advanced Filters

Found 1110 clinical trials

featured

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
For all genders
Family Medicine
Recruiting

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (SLATE)

The purpose of this study is to evaluate the safety and efficacy of the Visualase MRI Guided Laser Ablation System for narcotization or coagulation of epileptogenic foci in patients with intractable mesial temporal lobe epilepsy (MTLE)

temporal lobe epilepsy

seizure

32 views
23 Nov, 2020
1 location

featured

For Seniors
For adults
For all genders
Family Medicine
Recruiting

Stereotactic Laser Ablation for Temporal Lobe Epilepsy -SLATE-

The SLATE study is a prospective, single-arm, multicenter study. The study is being conducted to evaluate the safety and efficacy of the Visualase® MRI Guided Laser Ablation System.

seizure

97 views
11 Jun, 2020
1 location

featured

Phase 3
For pediatric ages
For adults
For all genders
Recruiting

Efficacy and Safety of Eslicarbazepine Acetate as adjunctive Therapy for refractory partial seizures in a double blind, randomized, placebo-controlled, parallel-group multicenter clinical trial

40 views
08 Nov, 2020
1 location

featured

For pediatric ages
For Seniors
For all genders
Obstetrics/Gynecology
Recruiting

Expanded Access with Adjunctive Ganaxolone (GNX) Treatment in Children and Young Adults with Cyclin-dependent Kinase-like 5 (CDKL5) deficiency disorder (CDD)

The primary objective is to provide GNX to patients ≥ 2 years with CDD-related seizures who are refractory to, or intolerant of, standard therapy.

0 views
30 Jun, 2021
2 locations

featured

For Seniors
For adults
For all genders
Family Medicine
Recruiting

[ONLINE] Alzheimer's Disease Center Research Registry

dementia. The study is intended to match people with studies that may be a good fit for them. Contact Person Michaela Riley Research Project Manager 312-503-5103

mild dementia

124 views
28 Jan, 2021
253 locations

featured

Phase 3
For pediatric ages
For Seniors
For all genders
Recruiting

Double blind, randomized, historical control study of the safety and efficacy of Eslicarbazepine Acetate Monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs

Double blind, randomized, historical control study of the safety and efficacy of Eslicarbazepine Acetate Monotherapy in subjects with partial epilepsy not well controlled by current antiepileptic drugs

598 views
08 Nov, 2020
1 location

featured

Phase 2
For adults
For all genders
Family Medicine
Recruiting

A phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants with Major Depressive Disorder

Praxis Precision Medicines is developing PRAX-114 (the study drug) as a possible new treatment for depression.Depression is a common but serious mood disorder. It causes severe symptoms that affect how you feel, think, and handle daily activities. Common symptoms of depression can include persistent feelings of sadness and loss of …

depressed mood

depressive symptoms

mood disorder